Status
Conditions
Study type
Funder types
Identifiers
About
This study is an observational cohort study of hospitalized patients with fever. This study will collect demographic data, history of illness, signs and symptoms, results of laboratory tests, clinical course, treatment and outcome. This study conducted at eight INA-RESPOND hospitals. Potential study patients will be any patients (both children and adults).
Full description
This study is an observational cohort to identify the etiologies of acute febrile illness (less than or equal to 2 weeks), which are thought to be endemic or novel in a certain area. Therefore, there are no hypotheses that require sample size calculation to be tested. It is expected that this study will enroll a minimum of 200 patients per site: approximately 100 adults and 100 pediatric cases. The final sample size is therefore estimated to be 1600.
Primary Objective:
To identify the etiology of acute febrile illness cases and evaluate clinical manifestations and outcomes.
Secondary Objectives:
This study will be conducted at all the INA-RESPOND hospitals (8 hospitals):
The study will enroll eligible fever patients for a period of up to 1 year. Follow-up may be up until one year after last subject is enrolled. Stored samples will be investigated during the study and/or after study completion.
After enrollment, patients will be seen at 14-28 days and at 3 months post enrollment. Patients will be seen every 3 months (6, 9, and 12 months within a window period of +/- 14 days) until cured and no related symptoms persists or the one year time point is reached. The samples will be collected for storage at enrollment, the 14-28 day visit, at 3 months and every 3 months thereafter if not cured.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Examples include, but not limited to: mental illness which could affect compliance with protocol, an anemic patient preventing blood draw.
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal